[Action of morphazinamide in treatment of pulmonary tuberculosis].
D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000188:drug therapy; D014394:Tuberculosis, Osteoarticular / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D011719:Pyrazines
Azione della morfazinamide nel trattamento della tubercolosi polmonare.